Progression and complications after external beam radiation therapy for carcinoma of prostate

Maurizio Brausi, Mark S. Soloway

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Sixty patients with prostatic carcinoma localized to the pelvis have been treated by external beam radiation therapy: 2 patients (2 %) were Stage A, 12 (20 %) Stage B, 14 (23 %) Stage C, and 32 (53 %) Stage Dl. Twenty-two patients received adjuvant therapy (11 estramustine phosphate [Estracyt] and 11 cyclophosphamide [Cytoxan]) after radiation. Progression occurred in 22 patients (37 %): 6 (10 %) had local recurrence while 16 (27 %) failed distally. The incidence of late major complications was 12 percent.

Original languageEnglish (US)
Pages (from-to)115-119
Number of pages5
JournalUrology
Volume34
Issue number3
DOIs
StatePublished - Sep 1989

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Progression and complications after external beam radiation therapy for carcinoma of prostate'. Together they form a unique fingerprint.

Cite this